NanoVibronix, Inc. Stock price
Is NanoVibronix, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,134 stocks worldwide.
Key metrics
NanoVibronix, Inc. Stock Analysis
Analyst Opinions
7 Analysts have issued a NanoVibronix, Inc. forecast:
Analyst Opinions
7 Analysts have issued a NanoVibronix, Inc. forecast:
Don't miss a Thing! We will send you all news about NanoVibronix, Inc. directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
NanoVibronix, Inc. engages in the development of noninvasive biological response-activating devices. It targets wound healing and pain therapy, and can be administered at home, without the assistance of medical professionals. Its products include WoundShield, PainShield, and UroShield. It operates through the following geographical segments: United States, Israel, United Kingdom, European Union, India, and Other. The company was founded by Harold Jacob and Jona Zumeris in September 2003 and is headquartered in Melville, NY.
| Head office | United States |
| CEO | Dr. Besser |
| Employees | 31 |
| Founded | 2003 |
| Website | nanovibronix.com |


